Share

ARMYDA 600*2

ARMYDA 600*2 - Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 600*2

Project objectives

Randomized study comparing a loading strategy of 600 mg clopidogrel versus 600 mg for two (two loads twelve hours apart) in patients undergoing percutaneous coronary revascularization.

Start and end date

February 2012 - ongoing

Project Manager

Dr. Giuseppe Patti - Local Principal Investigator

Prof. Germano Di Sciascio

Coordinating institution of the project

Università Campus Bio-Medico di Roma

QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right